The importance of plasma polymorphonuclear (PMN) elastase determination in patients with uveitis. 1997

N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
Department of Ophthalmology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.

OBJECTIVE Polymorphonuclear elastase is used as an important marker for inflammatory disease. We wanted to show whether polymorphonuclear elastase could be a marker in uveitis. METHODS Twenty-two patients with uveitis and 30 healthy control subjects were included in the study. Polymorphonuclear elastase levels were determined by immunoactivation method before and after periods of corticosteroid and/or cyclosporin treatments. RESULTS The levels were high in all of the patients before treatment; the levels reached normal range with treatment. In some cases, however, uveitis could not be suppressed in spite of treatment; these patients had high polymorphonuclear elastase levels. CONCLUSIONS It was concluded that determination of polymorphonuclear elastase level may be used for monitoring of uveitis.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
February 1993, Geburtshilfe und Frauenheilkunde,
N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
March 1996, Biological psychiatry,
N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
September 2018, European journal of medical research,
N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
December 1993, Endocrine journal,
N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
August 2009, International journal of andrology,
N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
October 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
December 2019, Journal of translational medicine,
N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
January 1980, Immunological communications,
N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
June 1986, Klinische Monatsblatter fur Augenheilkunde,
N Akyol, and O Değer, and H Erdöl, and Y Gedik, and A Orem, and H I Imamoglu
September 1977, Scandinavian journal of haematology,
Copied contents to your clipboard!